journal article·2021-08

Enantiomeric alkynyl-protected Au10 clusters with chirality-dependent radiotherapy enhancing effects

Tong-Tong Jia, Bing-Jie Li, Guang Yang, Yue Hua, Jun-Qi Liu, Wang Ma, Shuang-Quan Zang, Xiaoyuan Chen, Xueli Zhao

Nano Today· Volume 39
Publisher page

Abstract

Abstract Due to the homo-chirality preference of human body to most of chiral species, synthesizing enantiopure drugs and investigating the pharmacological activity of each enantiomer would have great meaning. However, the influence of chirality at nanoscale on the ability to enhance radiotherapy has not been studied. Herein, a pair of enantiomeric alkynyl-protected L/D-Au10(C13H17O5)10 nanoclusters (L/D-AuNCs) with strong chirality (g value up to 3.6 × 10-3) and circular polarization luminescence (glum ≈ 3 × 10-3) are prepared and applied as radiosensitizers. As a consequence, D-AuNCs exhibit better radiosensitization effect in vitro, which is confirmed by research on mechanisms including reactive oxygen species (ROS) burst mediated DNA breakage, cell cycle arrest and up-regulation of apoptotic protein expression. In vivo antitumor studies manifest that tumors treated with D-AuNCs and X-ray show a volume decrease of 51% compared with X-ray (4 Gy) only group. This work not only enriches the family of gold-based nano-radiosensitizers, but also further proves the significance of chirality in biomedicine.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanocluster Synthesis and Applications · Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (59)

Show source-provided references
1. Reorientation behavior in the helical motility of light-responsive spiral droplets10.1038/s41467-019-13201-6 ↗
2. The search for chiral asymmetry as a potential biosignature in our solar system10.1021/acs.chemrev.9b00474 ↗
3. Induction of chirality in a metal-organic framework built from achiral precursors10.1002/anie.202013885 ↗
4. Chiral DNA sequences as commutable controls for clinical genomics10.1038/s41467-019-09272-0 ↗
5. Chirality-selected chemical modulation of amyloid sggregation10.1021/jacs.8b12537 ↗
6. Reconfigurable plasmonic diastereomers assembled by DNA origami10.1021/acsnano.9b06734 ↗
7. Controlling the revolving and rotating motion direction of asymmetric hexameric nanomotor by arginine finger and channel chirality10.1021/acsnano.8b08849 ↗
8. Site-selective photoinduced cleavage and profiling of DNA by chiral semiconductor nanoparticles10.1038/s41557-018-0083-y ↗
9. Stereodivergent asymmetric synthesis of α/β-disubstituted β-aminoalkylboronic acid derivatives via group-selective protodeboronation enabling access to the elusive anti isomer10.1021/jacs.0c03207 ↗
10. Stereoselective synthesis, synthetic and pharmacological application of monoterpene-based 1,2,4- and 1,3,4-oxadiazoles10.3390/ijms19010081 ↗
11. Racemic drug resolution: a comprehensive guide10.1039/C6AY02015A ↗
12. Probing adsorption behaviors of BSA onto chiral surfaces of nanoparticles
13. Cross-fibrillation of insulin and amyloid β on chiral surfaces: Chirality affects aggregation kinetics and cytotoxicity10.1007/s12274-018-1995-y ↗
14. Stereospecific interactions between chiral inorganic nanomaterials and biological systems10.1039/D0CS00093K ↗
15. Gold nanoclusters for Parkinson’s disease treatment10.1016/j.biomaterials.2018.12.013 ↗
16. Chirality detection of enantiomers using twisted optical metamaterials10.1038/ncomms14180 ↗
17. Advances in chiral nanozymes: a review10.1007/s00604-019-3922-7 ↗
18. Chiral BINOL-based covalent organic frameworks for enantioselective sensing10.1021/jacs.9b02153 ↗
19. Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)10.1039/C8CS00457A ↗
20. Mesoporous encapsulated chiral nanogold for use in enantioselective reactions10.1002/anie.201811118 ↗
21. Preparation and characterization of chiral transition-metal dichalcogenide quantum dots and their enantioselective catalysis10.1021/acsami.8b10594 ↗
22. Amino-acid- and peptide-directed synthesis of chiral plasmonic gold nanoparticles10.1038/s41586-018-0034-1 ↗
23. Intracellular localization of nanoparticle dimers by chirality reversal10.1038/s41467-017-01337-2 ↗
24. Chiral supraparticles for controllable nanomedicine10.1002/adma.201903878 ↗
25. Intercluster aurophilicity-driven aggregation lighting circularly polarized luminescence of chiral gold clusters10.1007/s12274-020-2997-0 ↗
26. Enantiospecific desorption triggered by circularly polarized light10.1002/anie.201906630 ↗
27. Axially chiral biphenyl compound-based thermally activated delayed fluorescent materials for high-performance circularly polarized organic light-emitting diodes10.1002/advs.202000804 ↗
28. Stimulation of neural stem cell differentiation by circularly polarized light transduced by chiral nanoassemblies10.1038/s41551-020-00634-4 ↗
29. Tuning the interactions between chiral plasmonic films and living cells10.1038/s41467-017-02268-8 ↗
30. Engineering two-dimensional silicene composite nanosheets for dual-sensitized and photonic hyperthermia-augmented cancer radiotherapy10.1016/j.biomaterials.2020.120455 ↗
31. Photosynthetic biohybrid nanoswimmers system to alleviate tumor hypoxia for FL/PA/MR imaging‐guided enhanced radio‐photodynamic synergetic therapy
32. Stimuli-responsive small-on-large nanoradiosensitizer for enhanced tumor penetration and radiotherapy sensitization10.1021/acsnano.0c03094 ↗
33. Cancer radiosensitizers10.1016/j.tips.2017.11.003 ↗
34. Transition metal compounds as cancer radiosensitizers10.1039/C8CS00641E ↗
35. Tumor microenvironment-responsive multifunctional peptide coated ultrasmall gold nanoparticles and their application in cancer radiotherapy10.7150/thno.45017 ↗
36. Targeted radiosensitizers for MR-guided radiation therapy of prostate cancer10.1021/acs.nanolett.0c02487 ↗
37. Prostate-specific membrane antigen targeted gold nanoparticles for prostate cancer radiotherapy: does size matter for targeted particles?10.1039/C9SC02290B ↗
38. Enhanced radiosensitization by gold nanoparticles with acid-triggered aggregation in cancer radiotherapy
39. Ultrasmall Au(10-12)(SG)(10-12) nanomolecules for high tumor specificity and cancer radiotherapy10.1002/adma.201400866 ↗
40. Enhanced tumor accumulation of sub-2 nm gold nanoclusters for cancer radiation therapy10.1002/adhm.201300189 ↗
41. Atomically precise gold-levonorgestrel nanocluster as a radiosensitizer for enhanced cancer therapy10.1021/acsnano.9b03767 ↗
42. Synthesis of substituted mono- and diindole C-nucleoside analogues from sugar terminal alkynes by sequential sonogashira/heteroannulation reaction10.1021/jo501488x ↗
43. Synthetic routes to N-(1-deoxy-D-fructos-1-yl)amino acids by way of reductive amination of hexos-2-uloses10.1016/0008-6215(87)80273-2 ↗
44. Synthesis, structure and reactivity of stable homoleptic gold(I) alkene cations10.1002/chem.200902566 ↗
45. Alkynyl-protected Au22(C≡CR)18 clusters featuring new interfacial motifs and R-dependent photoluminescence10.1021/acs.jpclett.9b02920 ↗
46. Isomerization in alkynyl-protected gold nanoclusters10.1021/jacs.9b11836 ↗
47. Tuning the properties of atomically precise gold nanoclusters for biolabeling and drug delivery10.1039/D0CC03498C ↗
48. Structure determination of alkynyl-protected gold nanocluster Au22(tBuC≡C)18 and its thermochromic luminescence10.1002/anie.201912984 ↗
49. First enantioseparation and circular dichroism spectra of Au38 clusters protected by achiral ligands10.1038/ncomms1802 ↗
50. Chiroptical activity enhancement via structural control: the chiral synthesis and reversible interconversion of two intrinsically chiral gold nanoclusters10.1021/jacs.8b11096 ↗
51. From symmetry breaking to unraveling the origin of the chirality of ligated Au13Cu2 nanoclusters10.1002/anie.201800327 ↗
52. More is better: aggregation induced luminescence and exceptional chirality and circularly polarized luminescence of chiral gold clusters10.1039/D0QM00552E ↗
53. Self-assembly of chiral gold clusters into crystalline nanocubes of exceptional optical activity10.1002/anie.201709827 ↗
54. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation10.1038/s41467-019-09397-2 ↗
55. Caspase-3 regulates YAP-dependent cell proliferation and organ size10.1016/j.molcel.2018.04.019 ↗
56. Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy10.1038/ncomms16078 ↗
57. Inhibition of anti-apoptotic Bcl-2 proteins in preclinical and clinical studies: current overview in cancer10.3390/cells9051287 ↗
58. Alliance with EPR effect: combined strategies to improve the EPR effect in the tumor microenvironment10.7150/thno.37198 ↗
59. Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers10.1016/j.addr.2020.06.005 ↗